By Carlo Martuscelli

Fresenius SE & Co. KGaA (FRE.XE) said Monday that it has acquired CediMed, a Colombian diagnostics group, in an investment totaling about 40 million euros ($44.7 million).

The deal was executed through Quironsalud, Fresenius's Spanish private hospital group, and is aimed at strengthening the company's presence in Latin America's health-care services market.

Fresenius said it expects to close the deal in the next few months.

Write to Carlo Martuscelli at carlo.martuscelli@dowjones.com; @carlomartu

(END) Dow Jones Newswires

November 04, 2019 04:32 ET (09:32 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Fresenius SE & Co KGaA Charts.
Fresenius SE & Co KGaA (TG:FRE)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Fresenius SE & Co KGaA Charts.